About Us

BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.  The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D., and biotech business veteran, Y. Peter Li, Ph.D., M.B.A.  Drs. Cui, and Li are founders of Turning Point Therapeutics, Inc. which Bristol Myers Squibb acquired in June 2022 for $4.1 billion. BlossomHill Therapeutics, Inc. is headquartered in San Diego, California.